Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1992 1
2005 1
2013 2
2014 2
2015 2
2016 3
2017 6
2018 10
2019 6
2020 6
2021 14
2022 18
2023 9
2024 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.
Sartor O, de Bono J, Chi KN, Fizazi K, Herrmann K, Rahbar K, Tagawa ST, Nordquist LT, Vaishampayan N, El-Haddad G, Park CH, Beer TM, Armour A, Pérez-Contreras WJ, DeSilvio M, Kpamegan E, Gericke G, Messmann RA, Morris MJ, Krause BJ; VISION Investigators. Sartor O, et al. N Engl J Med. 2021 Sep 16;385(12):1091-1103. doi: 10.1056/NEJMoa2107322. Epub 2021 Jun 23. N Engl J Med. 2021. PMID: 34161051 Free PMC article. Clinical Trial.
PARP Inhibitors as Monotherapy in Daily Practice for Advanced Prostate Cancers.
Teyssonneau D, Thiery-Vuillemin A, Dariane C, Barret E, Beauval JB, Brureau L, Créhange G, Fiard G, Fromont G, Gauthé M, Ruffion A, Renard-Penna R, Mathieu R, Sargos P, Rouprêt M, Ploussard G, Roubaud G, On Behalf Of The Cc-Afu Cancerology Committee Of The Association Française d'Urologie. Teyssonneau D, et al. Among authors: gauthe m. J Clin Med. 2022 Mar 21;11(6):1734. doi: 10.3390/jcm11061734. J Clin Med. 2022. PMID: 35330059 Free PMC article. Review.
PARP inhibitors in prostate cancers, is it time for combinations?
Teyssonneau D, Dariane C, Barret E, Beauval JB, Brureau L, Fiard G, Fromont G, Créhange G, Gauthé M, Ruffion A, Renard-Penna R, Mathieu R, Sargos P, Rouprêt M, Ploussard G, Roubaud G. Teyssonneau D, et al. Among authors: gauthe m. Ther Adv Med Oncol. 2024 May 31;16:17588359241242959. doi: 10.1177/17588359241242959. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38827177 Free PMC article. Review.
Biomarker in Active Surveillance for Prostate Cancer: A Systematic Review.
Manceau C, Fromont G, Beauval JB, Barret E, Brureau L, Créhange G, Dariane C, Fiard G, Gauthé M, Mathieu R, Renard-Penna R, Roubaud G, Ruffion A, Sargos P, Rouprêt M, Ploussard G, On Behalf Of The Cc-Afu Cancerology Committee Of The Association Française d'Urologie. Manceau C, et al. Among authors: gauthe m. Cancers (Basel). 2021 Aug 24;13(17):4251. doi: 10.3390/cancers13174251. Cancers (Basel). 2021. PMID: 34503059 Free PMC article. Review.
Overview of the Development and Use of Akt Inhibitors in Prostate Cancer.
Gasmi A, Roubaud G, Dariane C, Barret E, Beauval JB, Brureau L, Créhange G, Fiard G, Fromont G, Gauthé M, Ruffion A, Renard-Penna R, Sargos P, Rouprêt M, Ploussard G, Mathieu R. Gasmi A, et al. Among authors: gauthe m. J Clin Med. 2021 Dec 29;11(1):160. doi: 10.3390/jcm11010160. J Clin Med. 2021. PMID: 35011901 Free PMC article. Review.
Vasectomy and Risk of Prostate Cancer: A Systematic Review and Meta-analysis.
Baboudjian M, Rajwa P, Barret E, Beauval JB, Brureau L, Créhange G, Dariane C, Fiard G, Fromont G, Gauthé M, Mathieu R, Renard-Penna R, Roubaud G, Ruffion A, Sargos P, Rouprêt M, Ploussard G; Prostate Cancer Committee of the Association Française d'Urologie CC-AFU. Baboudjian M, et al. Among authors: gauthe m. Eur Urol Open Sci. 2022 May 19;41:35-44. doi: 10.1016/j.euros.2022.04.012. eCollection 2022 Jul. Eur Urol Open Sci. 2022. PMID: 35633829 Free PMC article. Review.
Response to Letter to the Editor From Jagannath and Mayilvaganan: "FCH-PET/CT in Primary Hyperparathyroidism With Discordant/Negative MIBI Scintigraphy and Ultrasonography".
Koumakis E, Gauthé M, Martinino A, Sindayigaya R, Delbot T, Wartski M, Clerc J, Roux C, Borderie D, Cochand-Priollet B, Cormier C, Gaujoux S. Koumakis E, et al. Among authors: gauthe m. J Clin Endocrinol Metab. 2024 Feb 20;109(3):e1318-e1319. doi: 10.1210/clinem/dgad615. J Clin Endocrinol Metab. 2024. PMID: 37846771 No abstract available.
What is the ideal combination therapy in de novo, oligometastatic, castration-sensitive prostate cancer?
Baboudjian M, Roubaud G, Fromont G, Gauthé M, Beauval JB, Barret E, Brureau L, Créhange G, Dariane C, Fiard G, Mathieu R, Ruffion A, Rouprêt M, Renard-Penna R, Sargos P, Ploussard G; Prostate Cancer Committee of the French Association of Urology. Baboudjian M, et al. Among authors: gauthe m. World J Urol. 2023 Aug;41(8):2033-2041. doi: 10.1007/s00345-022-04239-1. Epub 2022 Dec 9. World J Urol. 2023. PMID: 36484817 Review.
72 results